Managing Cabotegravir During Pregnancy 

Event Description

Room 407

ential implications for both maternal health and fetal development. This lecture will explore the intricate balance between the benefits of preventing HIV acquisition and the potential risks associated with Cabotegravir use. Attendees will gain insights into the latest clinical research, real-world case studies, and guidelines that inform decision-making processes when contemplating Cabotegravir therapy for pregnant patients. By attending, you’ll gain a comprehensive understanding of the nuanced considerations surrounding Cabotegravir use in pregnant patients,enabling you to provide the highest level of care and support for this unique patient population.

Workshop Objectives:

1. Provide healthcare providers with a comprehensive understanding of the pharmacokinetics of Cabotegravir during pregnancy, its potential effects on fetal development, and its impact on maternal health outcomes and viral load management. 
2. Additionally, this workshop aims to compare Cabotegravir with other antiretroviral medications, discuss the existing clinical guidelines and recommendations for pregnant individuals, and equip participants with effective patient counseling and shared decision-making skills.

Presenters

Dr William Short